Literature DB >> 15993592

Developing microcolin A analogs as biological probes.

Amit K Mandal1, John Hines, Kouji Kuramochi, Craig M Crews.   

Abstract

Three microcolin A and B analogs have been synthesized. Their biological activity profiles were evaluated against several cell lines, revealing the existence of a structural determinant whose role in mediating the antiproliferative effect of the microcolins has heretofore gone unrecognized. While previously described as potent immunosuppressive natural products, we found that these microcolin analogs possessed no selective cytotoxicity when comparing immune cell versus nonimmune cell proliferation. In addition, the amino-terminus of microcolin A has been modified to incorporate a biotinylated polyethylene glycol linker. The biological activity of this biotinylated microcolin A analog was determined. This affinity reagent was shown to retain limited biological activity and thus can serve as a useful probe for elucidating the mechanism of action of microcolin A.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15993592      PMCID: PMC2507739          DOI: 10.1016/j.bmcl.2005.06.020

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  11 in total

Review 1.  Chemical genetics: exploring and controlling cellular processes with chemical probes.

Authors:  C M Crews; U Splittgerber
Journal:  Trends Biochem Sci       Date:  1999-08       Impact factor: 13.807

2.  Microcolins A and B, new immunosuppressive peptides from the blue-green alga Lyngbya majuscula.

Authors:  F E Koehn; R E Longley; J K Reed
Journal:  J Nat Prod       Date:  1992-05       Impact factor: 4.050

3.  Induction of apoptosis in mouse thymocytes by microcolin A and its synthetic analog.

Authors:  L H Zhang; R E Longley
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

4.  Analogues of the marine immunosuppressant microcolin A: preparation and biological activity.

Authors:  F E Koehn; O J McConnell; R E Longley; S H Sennett; J K Reed
Journal:  J Med Chem       Date:  1994-09-16       Impact factor: 7.446

5.  Eponemycin exerts its antitumor effect through the inhibition of proteasome function.

Authors:  L Meng; B H Kwok; N Sin; C M Crews
Journal:  Cancer Res       Date:  1999-06-15       Impact factor: 12.701

6.  Antiproliferative and immunosuppressive properties of microcolin A, a marine-derived lipopeptide.

Authors:  L H Zhang; R E Longley; F E Koehn
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

7.  Short, highly efficient syntheses of protected 3-azido- and 4-azidoproline and their precursors.

Authors:  J A Gómez-Vidal; R B Silverman
Journal:  Org Lett       Date:  2001-08-09       Impact factor: 6.005

8.  The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase.

Authors:  B H Kwok; B Koh; M I Ndubuisi; M Elofsson; C M Crews
Journal:  Chem Biol       Date:  2001-08

9.  Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity.

Authors:  L Meng; R Mohan; B H Kwok; M Elofsson; N Sin; C M Crews
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

10.  Stereoselectivity of muscarinic receptors in vivo and in vitro for oxotremorine analogues. N-[4-(tertiary amino)-2-butynyl]-5-methyl-2-pyrrolidones.

Authors:  R Amstutz; B Ringdahl; B Karlén; M Roch; D J Jenden
Journal:  J Med Chem       Date:  1985-12       Impact factor: 7.446

View more
  1 in total

1.  Bioassay-guided isolation and identification of desacetylmicrocolin B from Lyngbya cf. polychroa.

Authors:  Theresa Meickle; Susan Matthew; Cliff Ross; Hendrik Luesch; Valerie Paul
Journal:  Planta Med       Date:  2009-05-08       Impact factor: 3.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.